(50 days)
No
The document describes a medical monitor and does not mention any AI or ML capabilities.
No.
The device is a monitor intended for displaying and viewing medical images for diagnosis, not for treating diseases or conditions.
Yes
The device is described as "intended to be used in displaying and viewing medical images for diagnosis by trained Medical practitioners," which directly states its role in the diagnostic process.
No
The device description clearly identifies the device as a 21.3-inch Color LCD monitor, which is a hardware component.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In vitro diagnostics are tests performed on samples taken from the human body, such as blood, urine, or tissue, to detect diseases, conditions, or infections.
- Device Function: The description clearly states that this device is a monitor intended for displaying and viewing medical images. It does not perform any tests on biological samples.
- Intended Use: The intended use is for diagnosis by trained medical practitioners based on viewing images, not on analyzing biological samples.
Therefore, this device falls under the category of a medical image display device, not an in vitro diagnostic device.
N/A
Intended Use / Indications for Use
21.3 inch (54 cm) Color 3M pixel LCD Monitor, CCL356i2 (CL21356) is intended to be used in displaying and viewing medical images for diagnosis by trained medical practitioners. It is not meant to be used for digital mammography.
Product codes
LLZ
Device Description
CCL356i2 (CL21356) is a 21.3-inch (54 cm) Color LCD monitor whose display resolution is 1536 x 2048 (landscape), 2048 x 1536 (portrait) supporting DVI (digital visual interface) and Display Port.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
medical practitioners
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Not Found
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 892.2050 Medical image management and processing system.
(a)
Identification. A medical image management and processing system is a device that provides one or more capabilities relating to the review and digital processing of medical images for the purposes of interpretation by a trained practitioner of disease detection, diagnosis, or patient management. The software components may provide advanced or complex image processing functions for image manipulation, enhancement, or quantification that are intended for use in the interpretation and analysis of medical images. Advanced image manipulation functions may include image segmentation, multimodality image registration, or 3D visualization. Complex quantitative functions may include semi-automated measurements or time-series measurements.(b)
Classification. Class II (special controls; voluntary standards—Digital Imaging and Communications in Medicine (DICOM) Std., Joint Photographic Experts Group (JPEG) Std., Society of Motion Picture and Television Engineers (SMPTE) Test Pattern).
0
TOTOKU 11/2604
510(k) SUMMARY
| Submitted Information: | TOTOKU ELECTRIC CO., LTD.
300 Oya, Ueda
Nagano 386-0192 Japan |
|--------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Contact Person: | Tsukasa Tashiro, General Manager
Email: tasirot@totoku.co.jp
Tel: +81.258.24.6611
Fax: +81.258.24.6617 |
| Date Prepared: | September 2, 2011 |
| Device Name: | 21.3 inch (54 cm) Color LCD Monitor CCL3562 (CL21356) |
| Common Name: | CCL356i2, CL21356 |
| Classification Name: | Class II
(Part 892 Radiology Devices
Sec. 892.2050 Picture Archiving and Communication System) |
| Predicate Device: | 21.3 inch (54 cm) Color LCD Monitor CCL354i2 (CDL2126A)
(K081056) |
| Device Description: | CCL356i2 (CL21356) is a 21.3-inch (54 cm) Color LCD monitor
whose display resolution is 1536 x 2048 (landscape), 2048 x 1536
(portrait) supporting DVI (digital visual interface) and Display Port. |
| Intended Use: | 21.3 inch (54 cm) Color 3M pixel LCD Monitor, CCL356i2 (CL21356)
is intended to be used in displaying and viewing medical images
for diagnosis by trained medical practitioners. It is not meant to be
used for digital mammography. |
| Substantial Equivalence: | CCL3562 (CL21356) shares the same characteristics with our
predicate device CCL354i2 (K081056) except for the power supply. |
TOTOKU ELECTRIC CO., LTD. Intelligent Devices and Solutions Division 300 Oya, Ueda, Nagano 386-0192 Japan
TOTOKU ELECTRIC CO., LTD.
1
Image /page/1/Picture/0 description: The image shows the logo for the U.S. Department of Health and Human Services. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES • USA" around the perimeter. Inside the circle is a stylized symbol that resembles an abstract caduceus or a representation of the human form.
DEPARTMENT OF HEALTH & HUMAN SERVICES
Public Health Service
Food and Drug Administration 10903 New Hampshire Avenue Document Control Room - WO66-G609 Silver Spring, MD 20993-0002
Mr. Tsukasa Tashiro General Manager TOTOKU Electric Co., Ltd. 300 Oya, Ueda Nagano, 386-0192 JAPAN
OCT 2 7 2011
Re: K112604
Trade/Device Name: 21.3 inch (54 cm) Color LCD Monitor CCL356i2 (CL21356) Regulation Number: 21 CFR 892.2050 Regulation Name: Picture archiving and communications system Regulatory Class: II Product Code: LLZ Dated: September 2, 2011 Received: September 7, 2011
Dear Mr. Tashiro:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into class II (Special Controls), it may be subject to such additional controls. Existing major regulations affecting your device can be found in Title 21. Code of Federal Regulations (CFR), Parts 800 to 895. In addition, FDA may publish fruther announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. Your must comply with all the Act's requirements, including, but not limited to: registration and liating (21 CFR Part 807); labeling (21 CFR Parts 801 and 809); medical device reporting of
2
Enclosure
medical device-related adverse events) (21 CFR 803); and good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820). This letter will allow you to begin marketing your device as described in your Section 5.10(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Parts 801 and 809), please contact the Office of In Vitro Diagnostic Device Evaluation and Safety at (301) 796-5450. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportalProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.
Sincerely Yours.
Mary Pastel
Mary S. Pastel, Sc.D. Director Division of Radiological Devices Office of In Vitro Diagnostic Device Evaluation and Safety Center for Devices and Radiological Health
3
KI12604
INDICATIONS FOR USE
510(k) Number: Not known
Device Name: 21.3 inch (54 cm) Color LCD Monitor CCL356i2 (CL21356)
Indications for Use:
21.3 inch (54 cm) Color 3M pixel LCD Monitor CCL356i2 (CL21356) is intended to be used in displaying and viewing medical images for diagnosis by trained Medical practitioners. It is not meant to be used in digital mammography.
Image /page/3/Picture/6 description: The image shows the text "Prescription Use" on the left side of the image. To the right of the text, there is a check mark. The check mark is black and bolded. The check mark is above a horizontal line.
/
AND/OR Over-The-Counter Use
(Part 21 CFR 801 Subpart D)
(Part 21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE OF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Office of In Vitro Diagnostic Devices
Division of Radiological Devices Evaluation and Safety
(Division Sign-Off)
510K K112604
TOTOKU ELECTRI Intelligent Devices and Solutions D 300 Oya, Ueda, Nagano 386-0192 Japan
Page 10/460